ESTABLISHMENT LABS HOLDINGS (ESTA) Stock News

Establishment Labs Hosting Investor Day on June 12

Establishment Labs to Present at Jefferies Global Healthcare Conference

This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Mentions: OMCL REGN AEE PVH

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates

Establishment Labs (ESTA) delivered earnings and revenue surprises of 15.66% and 0.06%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: PACS

Establishment Labs Reports First Quarter 2025 Financial Results

Earnings Scheduled For May 7, 2025

Mentions: XPER EMR BLZE ERII ...

Establishment Labs Appoints Peter Caldini as Chief Executive Officer

Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mentions: VTRS

Earnings Preview: Establishment Labs Holdings Inc. (ESTA) Q1 Earnings Expected to Decline

Establishment Labs (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs to Announce First Quarter 2025 Financial Results on May 7

Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12

Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025

Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®

/PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness,...

Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance

Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference

Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day

Establishment Labs Launches Preservé™

Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26

Establishment Labs Announces CEO Transition

Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Establishment Labs Announces Participation in Upcoming Investment Conferences

Establishment Labs Announces $50 Million Registered Direct Offering

Establishment Labs Reports Third Quarter 2024 Financial Results

Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants

Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7

Establishment Labs Publishes 2024 Post Market Surveillance Report

First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants

Establishment Labs Receives U.S. FDA Approval for Motiva Implants